Ensign Peak Advisors, Inc Gilead Sciences, Inc. Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 1,609,397 shares of GILD stock, worth $145 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

1,609,397

Previous 1,428,838 12.64%

Holding current value

$145 Million

Previous $98 Million 37.61%

% of portfolio

0.24%

Previous 0.18%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $12 Million - $15.2 Million	180,559 Added 12.64%	1,609,397 $135 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $311,961 - $360,027	-4,940 Reduced 0.34%	1,428,838 $98 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $111 Million - $135 Million	-1,545,570 Reduced 51.88%	1,433,778 $105 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $43.9 Million - $49.8 Million	-599,352 Reduced 16.75%	2,979,348 $241 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $4.66 Million - $5.08 Million	-62,976 Reduced 1.73%	3,578,700 $268 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $5.02 Million - $5.72 Million	66,002 Added 1.85%	3,641,676 $281 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $29.7 Million - $33.9 Million	-384,720 Reduced 9.71%	3,575,674 $297 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $32.7 Million - $46.9 Million	-524,375 Reduced 11.69%	3,960,394 $340 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $107 Million - $122 Million	1,790,559 Added 66.46%	4,484,769 $277 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $28.2 Million - $31.8 Million	489,240 Added 22.19%	2,694,210 $167 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $37.7 Million - $47.2 Million	650,488 Added 41.85%	2,204,970 $131 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $28.1 Million - $31.9 Million	-432,547 Reduced 21.77%	1,554,482 $113 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $8.96 Million - $9.67 Million	-132,383 Reduced 6.25%	1,987,029 $139 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $17.3 Million - $18.9 Million	272,079 Added 14.73%	2,119,412 $146 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $16.3 Million - $18.6 Million	271,021 Added 17.19%	1,847,333 $119 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $29.4 Million - $33.5 Million	519,718 Added 49.19%	1,576,312 $91.8 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $12.3 Million - $15.4 Million	-197,800 Reduced 15.77%	1,056,594 $66.8 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $17.7 Million - $20.5 Million	-244,281 Reduced 16.3%	1,254,394 $96.5 Million
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $39 Million - $50 Million	623,260 Added 71.2%	1,498,675 $112 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $53.9 Million - $59.3 Million	875,415 New	875,415 $56.9 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Gilead Sciences, Inc. Transaction History